Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book will cover primary roles of NKT cells in immunity to cancer, in both mouse tumor models and cancer patients. There are several chapters describing general aspects of NKT cells.
This book will cover primary roles of NKT cells in immunity to cancer, in both mouse tumor models and cancer patients. There are several chapters describing general aspects of NKT cells.
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with -galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with -galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Rezensionen
From the reviews: "This book is essentially a collection of reviews that introduce the reader to the wonderful world of iNKT cells, and how their powerful adjuvant properties are being utilised by different researchers. ... this book is worth reading whether you are a new student in the NKT field and want to learn more or whether you are a clinician with an interest in tumour immunology." (Salah Mansour, Immunology News, November, 2012)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der Steintor 70. V V GmbH (zukünftig firmierend: buecher.de internetstores GmbH)
Geschäftsführung: Monica Sawhney | Roland Kölbl
Sitz der Gesellschaft: Hannover
Amtsgericht Hannover HRB 227001
Steuernummer: 321/neu